Neurovascular device company Imperative Care (Campbell, Calif.) said today that it has completed the initial closing of an $85 million Series C financing round to support the commercial launch of its portfolio. The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences. Existing investors Ascension Ventures, Delos Capital, Rock Springs […]
deloscapital
Intrinsic Therapeutics raises $50m for Barricaid annular closure device
Intrinsic Therapeutics said today that it raised a $49 million debt-and-equity round for the Barricaid annular closure device for discectomies that it’s developing. The Boston-based company said the round consisted of a $28 million equity financing led by New Enterprise Assoc. and Delos Capital, plus a $21 million debt facility with CRG. Other backers included Greenspring Associates, Quadrille […]